Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ITPRIPL1 - Glucosamine treatment effect on KMH2 malignant lymphocytes
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PIF1 - Glucosamine treatment effect on KMH2 malignant lymphocytes
SLC38A10 - Glucosamine treatment effect on KMH2 malignant lymphocytes
BCAP31 - Glucosamine treatment effect on KMH2 malignant lymphocytes
MAATS1 - Glucosamine treatment effect on KMH2 malignant lymphocytes
PPP5C - Glucosamine treatment effect on KMH2 malignant lymphocytes
CCDC159 - Glucosamine treatment effect on KMH2 malignant lymphocytes
FIBP - Glucosamine treatment effect on KMH2 malignant lymphocytes
TMEM161A - Glucosamine treatment effect on KMH2 malignant lymphocytes
CYP1B1 - Glucosamine treatment effect on KMH2 malignant lymphocytes
GANAB - Glucosamine treatment effect on KMH2 malignant lymphocytes
DDX41 - Glucosamine treatment effect on KMH2 malignant lymphocytes
RRP12 - Glucosamine treatment effect on KMH2 malignant lymphocytes
ZDHHC5 - Glucosamine treatment effect on KMH2 malignant lymphocytes
RPTOR - Glucosamine treatment effect on KMH2 malignant lymphocytes
LOC100289656 - Glucosamine treatment effect on KMH2 malignant lymphocytes
SRSF1 - Glucosamine treatment effect on KMH2 malignant lymphocytes
UTP14A - Glucosamine treatment effect on KMH2 malignant lymphocytes
TAF6L - Glucosamine treatment effect on KMH2 malignant lymphocytes
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on